Pacylex Pharmaceuticals Inc
$187,700.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2021-2022
Canada
This project will enable the creation and optimization of deuterated PCLX-001 analogues designed to improve the therapeutic index of PCLX-001 and bring to market an improved compound: deuterated varia...